Post by
Smokey1958 on Oct 28, 2022 8:51pm
Why?
Any thoughts here on why individual trade volumes this week are over 3x higher than last week with essentially the same number of average trades per day?
At the end of the day today the Ask was once again thin at $.075. Is there any sense of a momentum shift that would clear the way for a price movement back up to $.10 without an FDA EUA? On spec alone these are still very cheap shares ....and it should become evident by the end of the year whether DME Authority can gain any significant traction at all with Venowave. While the initial units have been paid for it's obviously in everyone's best interests to see that the sale of the devices is accelerating.
Comment by
hk1966 on Oct 28, 2022 9:19pm
Yes momentum building in part due to getting the Medicare insurance codes which make it possible to prescribe Venowave to hundreds of thousands of people without out of pocket payments
Comment by
moonball32 on Oct 29, 2022 11:45am
Your guess is as good as anyone else's, there is no Rhime or reason with the sp, just traders having some fun I guess. As always, time will tell where this company ends up. Just nice to end the week in green for a change.
Comment by
Elguyu1 on Oct 30, 2022 10:57am
I am confident that Venowave will become an easy sale What I am more concerned is if Fia can keep them coming on a regular bases I mean would it be nice if we were informed that another shipment had arrived at the whole sellers instead of being left in the dark
Comment by
Vincenzovega on Oct 30, 2022 11:16am
Exactly! If sales grows in say in a year or 2 years at 25 times of what where doing annually now of $10 million of devices per year, share price will be at $1.00 without AcuVid. As you said its ALL UP TO FIA, who is leaving us in the dark